scholarly journals Effects of topical estrogen therapy on the vaginal microcirculation in women with vulvovaginal atrophy

2019 ◽  
Vol 38 (5) ◽  
pp. 1298-1304 ◽  
Author(s):  
Chantal M. Diedrich ◽  
Arnoud W. Kastelein ◽  
Filippo M. Verri ◽  
Maaike A. Weber ◽  
Can Ince ◽  
...  
Keyword(s):  
Estrogen Therapy ◽  
Vulvovaginal Atrophy ◽  
Topical Estrogen

Topical Estrogen Therapy for Androgenetic Alopecia in Menopausal Females

Dermatology ◽  
2004 ◽  
Vol 208 (2) ◽  
pp. 178-179 ◽  
Author(s):  
S. Georgala ◽  
A.C. Katoulis ◽  
C. Georgala ◽  
V. Moussatou ◽  
E. Bozi ◽  
...  
Keyword(s):  
Estrogen Therapy ◽  
Androgenetic Alopecia ◽  
Topical Estrogen

scholarly journals PIH2 Topical Estrogen Therapy in Postmenopausal Women - Indian Experience

2012 ◽  
Vol 15 (7) ◽  
pp. A638
Author(s):  
S. Donde ◽  
G. Uchit ◽  
N. Valanju
Keyword(s):  
Postmenopausal Women ◽  
Estrogen Therapy ◽  
Indian Experience ◽  
Topical Estrogen

scholarly journals Topical Estrogen Therapy for Hyperopia Correction in Vivo

2020 ◽  
Vol 61 (6) ◽  
pp. 55
Author(s):  
Ari Leshno ◽  
Katalin Prokai-Tatrai ◽  
Ygal Rotenstreich ◽  
Asaf Magid ◽  
Ettel Bubis ◽  
...  
Keyword(s):  
Estrogen Therapy ◽  
Topical Estrogen

A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women

2006 ◽  
Vol 13 (5) ◽  
pp. 737-743 ◽  
Author(s):  
Cheng-Yu Long ◽  
Cheng-Min Liu ◽  
Shih-Cheng Hsu ◽  
Chin-Hu Wu ◽  
Chiu-Lin Wang ◽  
...  
Keyword(s):  
Comparative Study ◽  
Sexual Function ◽  
Postmenopausal Women ◽  
Estrogen Therapy ◽  
Topical Estrogen

Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview

Climacteric ◽  
2009 ◽  
Vol 12 (2) ◽  
pp. 91-105 ◽  
Author(s):  
O. Al-Baghdadi ◽  
A. A. A. Ewies
Keyword(s):  
Estrogen Therapy ◽  
Vaginal Atrophy ◽  
Topical Estrogen

New developments in topical estrogen therapy

1997 ◽  
Vol 67 (1) ◽  
pp. 1-12 ◽  
Author(s):  
Raphael Jewelewicz
Keyword(s):  
Estrogen Therapy ◽  
New Developments ◽  
Topical Estrogen

95060881 Investigation of local and systemic effects of topical estrogen therapy in menopausal period

Maturitas ◽  
1995 ◽  
Vol 22 (3) ◽  
pp. 266
Author(s):  
M. Kesim ◽  
F.F. Taser
Keyword(s):  
Estrogen Therapy ◽  
Systemic Effects ◽  
Topical Estrogen

scholarly journals Treatment of postmenopausal vulvovaginal atrophy with estriol: a scientific update for 2014–2018

2019 ◽  
Vol 13 (3) ◽  
pp. 227-238 ◽  
Author(s):  
A. D. Makatsariya ◽  
D. V. Blinov ◽  
V. O. Bitsadze ◽  
J. Kh. Khizroeva
Keyword(s):  
Quality Of Life ◽  
Negative Impact ◽  
Estrogen Therapy ◽  
Life Time ◽  
Reproductive Period ◽  
Vaginal Mucosa ◽  
Vulvovaginal Atrophy ◽  
Vaginal Cream ◽  
Long Time

Due to the increase in life expectancy, today, most women live in a state of estrogen deficiency for more than a third of their life time. According to the recent document on the stages of aging of the female reproductive system (the STRAW+10 working group), there are three main stages that include the reproductive period, the menopausal transition, and postmenopause. One of the most common manifestations of postmenopause is vulvovaginal atrophy or genitourinary syndrome, which leads to a dramatic decrease in the woman’s quality of life. Up to 45 % of postmenopausal women suffer from this disorder, and 80 % of them experience a negative impact on their quality of life. The main symptoms of vulvovaginal atrophy are dryness, itching, burning, and dyspareunia. Caution must be exercised in relation to “silent” atrophy, which is not manifested by subjective complaints of vaginal mucosa atrophy, and can only be visualized by colposcopy. According to the recommendations of the International Menopause Society (IMS), updated in 2016, therapy should be started before the atrophic changes become irreversible; the treatment should continue for a long time to maintain the achieved therapeutic effect. If no symptoms other than vulvovaginal atrophy are noted, local estrogen therapy is indicated. Estriol has advantages over other medications due to its lower affinity for estrogen receptors. In earlier studies as well as those updated here (2014–2018), estriol applied topically as a vaginal cream or vaginal suppositories, has a selective effect on the urogenital tract and practically does not interfere with the proliferation of the uterine endometrium. The confirmed efficacy and safety of estriol allow for its permanent use, beginning with the starting dose and then switching to the maintenance one.

Treatment of Labial Fusion with Topical Estrogen Therapy

2005 ◽  
Vol 44 (3) ◽  
pp. 245-247 ◽  
Author(s):  
Alexander K. C. Leung ◽  
W. Lane M. Robson ◽  
C. Pion Kao ◽  
Edmond K. H. Liu ◽  
Justine H. S. Fong
Keyword(s):  
Estrogen Therapy ◽  
Labial Fusion ◽  
Topical Estrogen
Sign in / Sign up

Export Citation Format

Share Document